We are live on
!
Find out more
WCM
Wedge Capital Management Portfolio holdings
AUM
$6.06B
1-Year Est. Return
47.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.29%
1 Year Est. Return
+47.24%
3 Year Est. Return
+138.72%
5 Year Est. Return
+177.67%
10 Year Est. Return
+528.98%
AUM
$10.3B
AUM Growth
+$351M
(+3.5%)
Cap. Flow
+$457M
Cap. Flow
% of AUM
4.43%
Top 10 Holdings %
Top 10 Hldgs %
15.71%
Holding
646
New
55
Increased
241
Reduced
247
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Packaging Corp of America
PKG
|
+$92M |
| 2 |
Marvell Technology
MRVL
|
+$86M |
| 3 |
Eastman Chemical
EMN
|
+$69.5M |
| 4 |
CarMax
KMX
|
+$55.2M |
| 5 |
Toll Brothers
TOL
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$66.9M |
| 2 |
Humana
HUM
|
+$53.7M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$52.6M |
| 4 |
AbbVie
ABBV
|
+$52.3M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$51.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.8% |
| 2 | Consumer Discretionary | 17.05% |
| 3 | Industrials | 13.69% |
| 4 | Healthcare | 9.11% |
| 5 | Technology | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Keurig Dr Pepper
KDP
$42.8B
| $43.7M | 0.42% |
599,070
-81,975
| -12% | -$6.25M |
|
|
ESRX
77
DELISTED
Express Scripts Holding Company
ESRX
| $43.6M | 0.42% |
490,050
-126,225
| -20% | -$11M |
|
78
Labcorp
LH
$25.2B
| $43.5M | 0.42% |
417,742
-81,888
| -16% | -$8.52M |
|
79
Boston Scientific
BSX
$68.4B
| $43.4M | 0.42% |
+2,449,550
| New | +$43.8M |
|
80
Elevance Health
ELV
$81.5B
| $43.3M | 0.42% |
263,585
-83,275
| -24% | -$13.3M |
|
81
Stryker
SYK
$135B
| $43.2M | 0.42% |
452,140
-108,000
| -19% | -$10.2M |
|
82
Royal Caribbean
RCL
$86.8B
| $43M | 0.42% |
546,243
-536,666
| -50% | -$40.9M |
|
83
Johnson & Johnson
JNJ
$640B
| $42.9M | 0.42% |
440,081
-73,500
| -14% | -$7.36M |
|
|
UN
84
DELISTED
Unilever NV New York Registry Shares
UN
| $42.9M | 0.42% |
+1,024,450
| New | +$44.2M |
|
85
Amgen
AMGN
$209B
| $42.8M | 0.42% |
+278,900
| New | +$44.7M |
|
86
Pfizer
PFE
$143B
| $42.5M | 0.41% |
1,336,525
-269,297
| -17% | -$8.78M |
|
87
Philip Morris
PM
$309B
| $42.4M | 0.41% |
+528,475
| New | +$43.5M |
|
88
Merck
MRK
$322B
| $42.2M | 0.41% |
+777,537
| New | +$43.6M |
|
89
Parker-Hannifin
PH
$120B
| $41.8M | 0.41% |
359,313
-14,275
| -4% | -$1.72M |
|
90
UGI
UGI
$7.87B
| $41.7M | 0.4% |
1,211,365
+158,409
| +15% | +$5.62M |
|
91
3M
MMM
$91.8B
| $41.1M | 0.4% |
318,910
-8,880
| -3% | -$1.19M |
|
92
AstraZeneca
AZN
$269B
| $40.9M | 0.4% |
641,725
-120,200
| -16% | -$8.23M |
|
93
Cummins
CMI
$83.6B
| $40.8M | 0.4% |
310,834
-10,000
| -3% | -$1.38M |
|
94
Western Union
WU
$2.53B
| $40.8M | 0.4% |
2,005,275
-681,175
| -25% | -$14.5M |
|
95
Fluor
FLR
$6.54B
| $40.2M | 0.39% |
757,456
-26,850
| -3% | -$1.55M |
|
96
Autoliv
ALV
$9.14B
| $40M | 0.39% |
476,140
-81,545
| -15% | -$7.18M |
|
97
Pitney Bowes
PBI
$2.39B
| $39.9M | 0.39% |
1,918,088
-57,450
| -3% | -$1.29M |
|
|
AIRM
98
DELISTED
Air Methods Corp
AIRM
| $39.1M | 0.38% |
946,265
-18,930
| -2% | -$829K |
|
99
Sonoco
SON
$5.83B
| $37.4M | 0.36% |
872,379
-384,966
| -31% | -$17.3M |
|
100
Capital One
COF
$128B
| $35.5M | 0.34% |
403,235
-53,375
| -12% | -$4.48M |
|
Similar funds
HPG
EMPI
JWBC
EAM
AA
RCG
WHRC
CIS
Wedge Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Wedge Capital Management held 646 positions worth $10.3B, up 3.5% from $9.97B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wedge Capital Management deployed $457M of net new capital in Q2 2015, opening 55 new positions and adding to 241 existing holdings. Its largest new stake was Packaging Corp of America: 1,307,052 shares worth $81.7M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Cigna, an estimated $66.9M trimmed.
- Wedge Capital Management's largest Q2 2015 buy was Packaging Corp of America: 1,307,052 shares worth $81.7M.
- Wedge Capital Management added most to Eastman Chemical in Q2 2015, an estimated $69.5M increase.
- Wedge Capital Management's biggest Q2 2015 reduction was Cigna, cutting an estimated $66.9M.
- Wedge Capital Management fully exited Humana in Q2 2015, selling an estimated $53.7M.
- Wedge Capital Management's ten largest holdings make up 16% of its $10.3B portfolio in Q2 2015.
- Wedge Capital Management opened 55 new positions and closed 53 in Q2 2015.
- Wedge Capital Management's portfolio value rose 3.5% quarter-over-quarter to $10.3B.
Based on Wedge Capital Management's 13F filing for Q2 2015, filed 6 Aug 2015.